NCT01670435View on ClinicalTrials.gov

Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance

CompletedOBSERVATIONAL
Enrollment

3,274

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

October 31, 2010

Conditions
Infection
Interventions
DRUG

Ciprofloxacin (BAYQ3939)

Patient treated with Ciproxan as a first line treatment in daily clinical practice

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01670435 - Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance | Biotech Hunter | Biotech Hunter